key: cord-0872241-d0q3zt5w
authors: Lachén-Montes, Mercedes; Mendizuri, Naroa; Ausín, Karina; Echaide, Miriam; Blanco, Ester; Chocarro, Luisa; de Toro, María; Escors, David; Fernández-Irigoyen, Joaquín; Kochan, Grazyna; Santamaría, Enrique
title: Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions
date: 2022-02-02
journal: bioRxiv
DOI: 10.1101/2022.02.01.478724
sha: d86817a926ac115deb859c45cae22b15f9546a95
doc_id: 872241
cord_uid: d0q3zt5w

One of the most common symptoms in COVID-19 is a sudden loss of smell. SARS-CoV-2 has been detected in the olfactory bulb (OB) from animal models and sporadically in COVID-19 patients. To decipher the specific role over the SARS-CoV-2 proteome at olfactory level, we characterized the in-depth molecular imbalance induced by the expression of GFP-tagged SARS-CoV-2 structural proteins (M, N, E, S) on mouse OB cells. Transcriptomic and proteomic trajectories uncovered a widespread metabolic remodeling commonly converging in extracellular matrix organization, lipid metabolism and signaling by receptor tyrosine kinases. The molecular singularities and specific interactome expression modules were also characterized for each viral structural factor. The intracellular molecular imbalance induced by each SARS-CoV-2 structural protein was accompanied by differential activation dynamics in survival and immunological routes in parallel with a differentiated secretion profile of chemokines in OB cells. Machine learning through a proteotranscriptomic data integration uncovered TGF-beta signaling as a confluent activation node by the SARS-CoV-2 structural proteome. Taken together, these data provide important avenues for understanding the multifunctional immunomodulatory properties of SARS-CoV-2 M, N, S and E proteins beyond their intrinsic role in virion formation, deciphering mechanistic clues to the olfactory inflammation observed in COVID-19 patients.

The coronavirus disease 2019 is an ongoing viral pandemic caused by the rapid spread 64 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) . It is well known 65 that infection is transmitted by respiratory droplets with an incubation period of approximately 5 days 66 (Stadnytskyi et al., 2020) , however, there are still many gaps regarding the molecular mechanisms 67 disrupted during the infection and the immune system response triggered against this pathogen. The 68

approximately 30,000-nucleotide SARS-CoV-2 RNA genome encodes for 14 major open-reading 69 frames (ORFs). The 4 structural proteins (S (spike), membrane (M), envelope (E), and nucleocapside 70 (N)) are expressed from subgenomic RNAs transcribed from the RNA genome. In addition, SARS-71

CoV-2 expresses another 14 non-structural proteins and 8 accessory proteins which participate in 72 RNA replication-transcription, and pathogenesis (Naqvi et al., 2020) . The clinical presentation of 73 COVID-19 varies from asymptomatic, mild to moderate self-limiting disease in the majority of cases 74 (Huang et al., 2020) . However, fatal consequence can occur in patients with comorbidities (Guzik et 75 al., 2020; Yang et al., 2020) . SARS-CoV-2 infection in human patients include fever and respiratory 76 symptoms, such as fever, dry cough, dyspnea, and pneumonia (Huang et al., 2020) . In addition, 77 accumulating evidence has demonstrated the appearance of other symptoms of clinical importance, 78 such as neurological affectation and olfactory and gustatory dysfunctions, among others (Bagheri et 79 al., 2020; Beltran-Corbellini et al., 2020; Giacomelli et al., 2020; Menni et al., 2020; Parma et al., 80 2020; Gerkin et al., 2021) . Importantly from a diagnostic point of view, these changes usually occur 81 earlier than other symptoms, suggesting a potential specific predictive value (Haehner et al., 82 2020; Pierron et al., 2020) . 83

Although the molecular mechanisms of olfactory and neurological disorders in SARS-CoV-2-84 infected patients are not fully understood, there is growing evidence that the olfactory loss observed 85

in COVID-19 occurs through the infection of supporting cells in the olfactory system (Brann et al., 86 2020) . The key pathological mechanism of action for SARS-CoV-2 to invade the host cell involves 87 the S protein attachment to the human angiotensin-converting enzyme 2 (ACE2) cell surface protein. 88 Then, the virus uptake is facilitated by the action of the TMPRSS2 protease (Shang et al., 2020) . 89 Importantly, sustentacular cells highly express both ACE2 and TMPRSS2 proteins, while little 90 expression is found in olfactory neurons (Brann et al., 2020) . Therefore, these sustentacular cells 91 might be the main targets for SARS-CoV-2 infection, leaving the neurons vulnerable and depleted of 92 nutrients. However, other studies which focused on the olfactory epithelium from SARS-CoV-2-93 infected patients with acute loss of smell, point out that olfactory sensory neurons, support cells, and 94 immune cells are major sites of SARS-CoV-2 infection (de Melo et al., 2021) . Certain coronaviruses 95

have the ability to pass from the OE through the cribriform plate to infect the OB (Durrant et al., 96 2016; Dube et al., 2018) . In fact, several reports have detected evidences of SARS-CoV-2 at the OB 97 (Lou et al., 2021) . However, the neuroinvasive potential of SARS-CoV-2 and future neurological 98 vulnerabilities remain controversial (Cooper et al., 2020; Xydakis et al., 2021) . 99

Omics technologies have allowed to increase our knowledge about the molecular imbalance triggered 100 by the SARS-CoV-2 in multiple human organs as well as in-vitro systems (Lachen-Montes et al., 101 2020; Nie et al., 2021; Saccon et al., 2021; Stukalov et al., 2021) . However, there are still major gaps in 102 the pathways leading to loss of smell caused by SARS-CoV-2, in addition to the molecular 103 consequences from SARS-CoV-2 structural proteins at the olfactory level. Bearing in mind that the 104 olfactory loss is considered an early predictor of COVID-19, we consider that the methodologies 105 simulating SARS-CoV-2 infection in olfactory cells in combination with -omics strategies is a 106 straightforward approach to elucidate the host and viral mechanisms involved in SARS-CoV-2-107 induced anosmia. These approaches can also identify potential therapeutic targets for non-invasive 108 intranasal treatments. In this study, we have characterized the molecular dyshomeostasis induced by 109 each SARS-CoV-2 structural protein (S, N, M, E) in murine OBC1 cells as an olfactory in-vitro 110 system. The effects induced by the expression of GFP-tagged SARS- CoV-2 structural proteins  111  uncovered a tangled crosstalk between multiple biofunctions and pathways as well as an  112  immunological response differentially modulated by each SARS-CoV-2 structural protein. Our  113  results also identified novel viral-host protein interactions partially shared by the structural  114 components of the SARS-CoV-2 proteome. 115 Electrophoresis reagents were purchased from Bio-rad and trypsin from Promega. 127

Coding sequences for M, E, N and S proteins were retrieved from the SARS-CoV-2 reference 129 genome (https://www.ncbi.nlm.nih.gov/nuccore/1798174254). Coding sequences were further 130 codon-optimized for their expression in human cells, and recombinant synthetic genes fused to the 131 GFP-coding sequence at the 3-termini were ordered from GeneArt (ThermoFisher). Genes were 132 further cloned into pDUAL-PuroR lentivectors (Escors et al., 2008; Gato-Canas et al., 2017) under 133 the transcriptional control of the SFFV promoter. pDUAL-PuroR lentivectors express puromycin 134 resistance under the transcriptional control of the human ubiquitin promoter. 135

Immortalized murine olfactory bulb OBC1 cells (ABM. T0235) were cultured in DMEM (Gibco)  137 supplemented with 10% FBS (Merck Millipore) and 1% penicillin/streptomycin (ABM) and grown 138 in a 5% CO 2 humidified atmosphere at 37ºC. For transfection, OBC1 cells were seeded in 6-well 139

plates at a confluency of 80%. Twenty microliters of Fugene HD (Promega) were incubated 140 separately in 50 ul of DMEM without FBS and then mixed with three micrograms of M-GFP, E-141 GFP, N-GFP, S-GFP and control GFP plasmid DNA, followed by 15 min incubation at room 142 temperature. The cells were transfected in a 3ml total volume for 72 hours. After three days, the 143 culture medium was replaced with DMEM supplemented with 1ug/ml puromycin (Thermo). 144

Transfection efficiency was assessed using flow cytometry and to achieve a more specific population, 145

cell sorting based on GFP expression was performed among all experimental conditions. 146

Briefly, total RNA was extracted and purified using a RNeasy Mini Kit (Qiagen, Hilden, Germany) 148 following manufacturer's instructions. Sequencing libraries were prepared by following the Illumina 149 (Okonechnikov et al., 2016) and sorted and indexed with Samtools software (Li et al., 2009) . After 165 taking a read count on gene features with the FeatureCounts tool (http://subread.sourceforge.net) 166 (Liao et al., 2014) , quantitative differential expression analysis between conditions was performed by 167

DESeq2 (Love et al., 2014) , implemented as R Bioconductor package, performing read-count 168 normalization by following a negative binomial distribution model. In order to automate this process 169 and facilitate all group combination analysis, the SARTools pipeline (Varet et al., 2016) Eksigent nanoLC ultra 2D pump system (SCIEX, Canada) fitted with a 75 μ m ID column (Thermo 199 Scientific 0.075 × 250mm, particle size 3 μ m and pore size 100 Å). Prior to separation, the peptides 200

were concentrated on a C18 precolumn (Thermo Scientific 0.1 × 50mm, particle size 5 μ m and pore 201 size 100 Å). Mobile phases were 100% water 0.1% formic acid (FA) (buffer A) and 100% 202

Acetonitrile 0.1% FA (buffer B). Column gradient was developed in a gradient from 2% B to 40% B 203 in 120 min. Column was equilibrated in 95% B for 10 min and 2% B for 10 min. During all process, 204

precolumn was in line with column and flow maintained all along the gradient at 300 nl/min. Output 205 of the separation column was directly coupled to nano-electrospray source. MS1 spectra was 206 collected in the range of 350-1250 m/z for 250 ms. The 35 most intense precursors with charge states 207 of 2 to 5 that exceeded 150 counts per second were selected for fragmentation, rolling collision 208 energy was used for fragmentation and MS2 spectra were collected in the range of 230-1500 m/z for 209 100 ms. The precursor ions were dynamically excluded from reselection for 15 s. MS/MS data 210 acquisition was performed using AnalystTF 1.7 (Sciex) and spectra files were processed through 211

ProteinPilot v5.0 search engine (Sciex) using Paragon TM Algo-rithm (v.4.0.0.0) for database search. 212

To avoid using the same spectral evidence in more than one protein, the identified proteins were 213 grouped based on MS/MS spectra by the Progroup™ algorithm, regardless of the peptide sequence 214 assigned. The protein within each group that could explain more spectral data with confidence was 215 depicted as the primary protein of the group. FDR was performed using a non-lineal fitting method 216 (Tang et al., 2008) and displayed results were those reporting a 1% Global FDR or better. 217

Protein extracts (20 µg) from each sample were reduced by addition of DTT to a final concentration 219 of 10mM and incubation at room temperature for 30 minutes. Subsequent alkylation by 30 mM 220 iodoacetamide was performed for 30minutes in the dark. An additional reduction step was performed 221 by 30mM DTT, allowing the reaction to stand at room temperature for 30 min. The mixture was 222 diluted to 0.6M urea using MilliQ-water, and after trypsin addition (Promega) (enzyme:protein, 1:50 223 w/w), the sample was incubated at 37ºC for 16h. Digestion was quenched by acidification with acetic 224 acid. The digestion mixture was dried in a SpeedVac. Purification and concentration of peptides was 225 performed using C18 Zip Tip Solid Phase Extraction (Millipore). The peptides recovered were 226 reconstituted into a final concentration of 0.5µg/µL of 2% ACN, 0.5% FA, 97.5% MilliQ-water prior 227

to mass spectrometric analysis. For SWATH-MS-based experiments the instrument (Sciex 228

TripleTOF 5600+) was configured as described by Gillet et al (Gillet et al., 2012) . Briefly, the mass 229 spectrometer was operated in a looped product ion mode. In this mode, the instrument was 230 specifically tuned to allow a quadrupole resolution of Da/mass selection. The stability of the mass 231 selection was maintained by the operation of the Radio Frequency (RF) and Direct Current (DC) 232

voltages on the isolation quadrupole in an independent manner. Using an isolation width of 16 Da 233

(15 Da of optimal ion transmission efficiency and 1 Da for the window overlap), a set of 37 234 overlapping windows were constructed covering the mass range 450-1000 Da. In this way, 1 μ L of 235 each sample was loaded onto a trap column (Thermo Scientific 0.1 × 50mm, particle size 5 μ m and 236 pore size 100 Å) and desalted with 0.1% TFA at 3 μ L/min during 10 min. The peptides were loaded 237 onto an analytical column (Thermo Scientific 0.075 × 250mm, particle size 3 μ m and pore size 100 238 Å) equilibrated in 2% acetonitrile 0.1% FA. Peptide elution was carried out with a linear gradient of 239 2 to 40% B in 120 min (mobile phases A:100% water 0.1% formic acid (FA) and B: 100% 240 Acetonitrile 0.1% FA) at a flow rate of 300 nL/min. Eluted peptides were infused in the mass 241 spectrometer. The Triple-TOF was operated in swath mode, in which a 0.050 s TOF MS scan from 242 350 to 1250 m/z was performed, followed by 0.080 s product ion scans from 230 to 1800 m/z on the 243 37 defined windows (3.05 s/cycle). Collision energy was set to optimum energy for a 2 + ion at the 244 center of each SWATH block with a 15 eV collision energy spread. The mass spectrometer was 245 always operated in high sensitivity mode. The resulting ProteinPilot group file from library 246 generation was loaded into PeakView® (v2.1, Sciex) and peaks from SWATH runs were extracted 247 with a peptide confidence threshold of 99% confidence (Unused Score ≥ 1.3) and a FDR lower than 248

1%. For this, the MS/MS spectra of the assigned peptides was extracted by ProteinPilot, and only the 249 proteins that fulfilled the following criteria were validated: (1) peptide mass tolerance lower than 10 250 ppm, (2) 99% of confidence level in peptide identification, and (3) complete b/y ions series found in 251 the MS/MS spectrum. Only proteins quantified with at least two unique peptides were considered. 252

The quantitative data obtained by PeakView® were analyzed using Perseus software 1.6.14 version 253 (Tyanova et al., 2016) 

For the secretome analysis, a dot-blot protein array was used for cytokine profiling (Abcam). Briefly, 263 membranes with 62 cytokine antibodies were blocked with the manufacturer's blocking bu er at 264 room temperature (RT) for 30 min, and incubated o/n with 1 ml of undiluted cell-cultured media 265 from OBC1 transfected cells (n = 3/condition). After washing, a biotinylated anti-cytokine antibody 266 mixture was added to the membranes followed by incubation with HRP-conjugated streptavidin and 267 then exposed to the manufacturer's peroxidase substrate. 268

Equal amounts of protein (10 µg) were resolved in 4-15% stain free SDS-PAGE gels (BioRad 

Multiple studies have pointed out that SARS-CoV-2 infection affects the chemosensory processing in 285 animals and humans, especially the olfaction. SARS-CoV-2 is able to reach the OE and the OB in 286 mice and golden Syrian hamsters (de Melo et al., 2021; Ye et al., 2021) . In rhesus monkeys, SARS-287

CoV-2 also invades the CNS primarily via the OB (Jiao et al., 2021) . Although it has been proposed 288 that the olfactory nerve is not a likely route to brain infection in COVID-19 patients (Butowt et al., 289 2021) , several reports have shown the presence of SARS-CoV-2 (mRNA/protein levels or viral 290 particles) in multiple brain areas including the OB derived from COVID-19 patients (Deigendesch et 291 al., 2020; Matschke et al., 2020; Menter et al., 2020; Morbini et al., 2020; Lopez et al., 2021; Lou et al., 292 2021; Meinhardt et al., 2021; Serrano et al., 2021) . In particular, the S protein has the capacity to cross 293 the blood-brain barrier and reach the OB in mice (Rhea et al., 2021) . In view of these preclinical and 294

neuropathological data, an in-depth olfactory molecular characterization is necessary to unveil the 295 missing links in the mechanisms of the sudden smell impairment induced by SARS-CoV-2 infection. 296

To address this gap in knowledge, we have evaluated in-depth the OB cell response upon the 297 intracellular expression of the SARS-CoV-2 structural proteins. The S glycoprotein is the main 298

determinant of viral entry in target cells (Rhea et al., 2021) . The M glycoprotein is key for viral 299 particle assembly (Escors et al., 2001; de Haan and Rottier, 2005) , whereas the E protein is a 300 multifunctional protein, acting as a viroporin in its oligomeric form, participating on viral assembly 301 and virion release (Pervushin et al., 2009; Schoeman and Fielding, 2019) . The N protein packages the 302 positive strand viral genome RNA into a helical ribonucleocapsid (RNP), playing a fundamental role 303 during virion assembly through its interactions with the viral genome and membrane protein M 304 (Escors et al., 2001; Satarker and Nampoothiri, 2020) . In general, SARS-CoV-2 structural protein 305 factors are essential in the viral genome replication, receptor attachment and virion formation, 306

promoting the viral spreading and pathogenesis. 307

To examine the molecular alterations due to the presence of SARS-CoV-2 structural proteins in an 309

olfactory cell system, GFP-tagged SARS-CoV-2 structural proteins S, M, N and E were expressed in 310 OBC1 cells ( Figure 1A) . After GFP-positive cell sorting, the olfactory metabolic imbalance induced 311 by each SARS-CoV-2 protein was monitored across all experimental conditions by RNA-seq and 312 shotgun proteomics. At transcriptome level, 1506, 1440, 359 and 1237 differential expressed genes 313

were found between control-GFP and GFP-E, GFP-M, GFP-N and GFP-S SARS-CoV-2 proteins 314 respectively (p-value adjusted <0.01; fold-change: 50%) (Supplementary Table 1 ). In contrast, 315

around 15-23% of the quantified proteome was modulated by GFP-tagged SARS-CoV-2 structural 316 proteins. Specifically, 435, 387, 594 and 584 proteins differential expressed proteins (DEPs) were 317

found between Control-GFP and GFP-S, GFP-N, GFP-M and GFP-E respectively (p-value <0.05; 318

fold-change 30%) (Supplementary Table 2) . GFP-tagged SARS-CoV-2 proteins were detected by 319

Western-blotting (Supplementary Figure 1A) and mass-spectrometry (Supplementary Table 2 ) 320 except the GFP-E protein, due to its small size and the high content of aliphatic hydrophic 321 aminoacids in its sequence (36% of Leu and Val) (Duart et al., 2020) . Multiple commonalities and 322 differences were observed when transcriptomic and proteomic datasets derived from the expression 323 of GFP-tagged SARS-CoV-2 structural proteins were compared (Figure 1B-C; Supplementary  324 figures 1B, 2A). Focusing on the most affected proteins, we identified a downregulation in Ak4 325

(Adenylate kinase 4), a protein that controls ATP levels through the regulatory activity of AMPK 326 which plays a protective role against oxidative stress Lanning et al., 2014) . A 327 detailed functional clustering revealed that SARS-CoV-2 structural proteins independently impact on 328 multiple pathways at transcriptomic and proteomic levels (Supplementary figures 1C, 2B ; 329

Supplementary Tables 3-4). Comparing the functionality derived from both omic approaches, all 330 SARS-CoV-2 structural proteins commonly interferes with multiple biofunctions such as 331 extracellular matrix organization, deregulation of lipid metabolism, hemostasis, non-integrin 332 membrane interactions and signaling by receptor tyrosine kinases ( Figure 1D) . However, SARS-333

CoV-2 structural proteins commonly induced specific alterations with different impact on 334 transcriptomic homeostasis and proteostasis. Considering the most statistically significant enriched 335 pathways, SARS-CoV-2 proteins interfere with transcriptional activities associated to 336 chondroitin/dermatan sulphate metabolism, platelet homeostasis, PPAR-dependent gene expression, 337 opioid signaling, glycosylation and cytokine, IGF and PDGF signaling (Figure 1D) . At proteostatic 338 level, SARS-CoV-2 structural proteins modulate aminoacid metabolism, biological oxidations, 339

interleukin-12 signaling and processing of pre-mRNA and rRNA, between others ( Figure 1D) . 340

To decipher specificities and singularities associated to the expression of each SARS-CoV-2 341 structural protein at olfactory level, functional analyses were performed excluding the common 342 deregulated proteome and taking into account only the mapping of unique DEPs associated to each 343 SARS-CoV-2 protein (Supplementary Table 5 ). Interestingly, densely connected complexes with 344 regulatory roles in GTP hydrolysis, calcium uptake into mitochondria (processing SMDT1), nuclear 345 pore complex formation, vesicle-mediated transport, antigen presentation and peroxisomal protein 346 import were commonly altered by structural SARS-CoV-2 proteins (Figure 2 , upper). However, 347

protein components of these complexes were differentially targeted by each structural viral protein 348 (Figure 2, lower) . Inferring more biologically interpretable results, GFP-M significantly modulated 349 protein mediators located in organelle membranes that are mainly involved in trans-Golgi network 350 vesicle budding, ferroptosis and cellular response to chemical stress (Figure 3A and B) . GFP-S 351 independently impacted on nuclear proteins regulating cholesterol synthesis, DNA elongation and 352 mRNA splicing between others (Figure 3A and B) . GFP-E-dysregulated proteins presented a 353 widespread localization, affecting a plethora of non-related functions such as mRNA processing, 354 RAB geranylgeranylation and integrin interactions, whereas GFP-N specifically altered lipid, 355 glutathione and glyoxilate metabolism (Figure 3A and B) . In contrast to recent results with full viral 356 particles, these data generated at the organelle-complex-pathway axis demonstrate the enriched 357 multifactorial functions associated to each SARS-CoV-2 protein. Interestingly, 14-18% of the 358 perturbations generated by SARS-CoV-2 M, N and E proteins (at the level of protein-coding gene) in 359 OBC1 cells were common with data derived from pulmonary cells expressing these structural viral 360

proteins (Stukalov et al., 2021) (Figure 3C) . However, only 3% of the proteome modulated by the S 361 protein was shared across studies, indicating that a great proportion of proteostatic events intercepted 362 by structural SARS-CoV-2 proteins are cell-dependent. In addition, part of the altered molecular 363 routes identified in our in-vitro system have been recently detected in the OB from COVID-19 364 subjects (Piras et al., 2021) (Supplementary Figure 3) , pointing out specific pathways directly 365 targeted by SARS-CoV-2 structural proteins beyond the CNS affectation and/or the systemic immune 366 response to SARS-CoV-2 infection. 367

To enhance the analytical outcome of proteostatic alterations, proteome-scale interaction networks 370

were constructed merging the differential proteomes induced by SARS-CoV-2 structural proteins. As 371 shown in Figure 4 , both p38 MAPK and Akt appeared as principal nodes in protein interactome 372 maps. Although much effort has been spent on characterizing the pleiotropic effects of SARS-CoV-2 373 infection in multiple biological contexts, there is no detailed information about the impact of each 374 structural SARS-CoV-2 protein on the activation dynamics of the cell survival. Even though changes 375 in p38 MAPK and Akt expression were not detected in our proteomic analysis, the alteration of some 376 targets might be indicative of a dysfunctional state when SARS-CoV-2 structural proteins are 377 continuously expressed. Subsequent experiments were performed to analyze the activation state of 378 p38 MAPK and Akt signaling pathways across GFP-SARS-CoV-2 structural protein expressing-379 OBC1 cells ( Figure 5) . As shown in Figure 5A , the presence of SARS-CoV-2 structural proteins 380 induced a p38 MAPK and Akt inactivation. Specifically, the independent expression of SARS-CoV-2 381 S and N proteins inactivated both kinases. In contrast, the M protein specifically inactivated Akt and 382 the E protein interfered with p38 MAPK. To complement our signaling mapping, other stress-383 responsive kinases relevant to OB homeostasis (Lachen-Montes et al., 2019) were checked. N and S 384 proteins also induced the inactivation of GSK3 and the SEK1 stress-activated protein kinase (SAPK) 385 axis ( Figure 5B) . However, S protein expression induced the inactivation of PKA whereas the 386 expression of the N protein enhanced the active phosphorylation of the PKA catalytic subunit 387 ( Figure 5B) . No appreciable changes were observed in the activation profile of other survival kinases 388 such as PDK1, PKC, CaMKII and MEK1/2 (Supplementary Figure 4) . These data demonstrate that 389 SARS-CoV-2 structural proteins differentially impact on the survival potential of OB cells. Many 390 viral infections trigger the activation of the p38 MAPK and Akt signaling pathways for an efficient 391

replication, including SARS-CoV-2 (Kindrachuk et al., 2015; Appelberg et al., 2020; Cheng et al., 392 2020) . p38 MAPK and Akt inactivation induced by the expression of SARS-CoV-2 structural 393 proteins could be part of an antiviral mechanism triggered in olfactory cells. In fact, pharmacological 394 inhibition of p38 MAPK has antiviral efficacy (Bouhaddou et al., 2020; Grimes and Grimes, 2020) 395 and Akt inhibitors have been proposed as candidate drugs (Fagone et al., 2020) . Therefore, our 396 results are in agreement with evidence pointing to both kinases as potential therapeutic targets for 397 COVID-19. GSK3 is essential for N phosphorylation and SARS-CoV-2 replication . 398

Similarly to SARS-CoV-1, GSK3 activity may be also critical for the initiation of oxidative stress, 399

and inflammation during SARS-CoV-2 infection (Rana et al., 2021) , raising the possibility that 400 targeting GSK-3 could open new therapeutic opportunities in COVID-19 (Rudd, 2020) . SEK1 401 (MKK4) is an essential component of the stress-activated protein kinase/c-Jun N-terminal kinase 402

(SAP/JNK) signaling pathway that is phosphorylated by the avian coronavirus infectious bronchitis 403 virus (IBV) (Fung and Liu, 2017) . However, the mechanistic connection with SARS-CoV-2 is not 404 known. We observed an enhanced PKA activity when SARS-CoV-2 N protein is overexpressed in 405 OBC1 cells. Interestingly, the co-expression of PKA and N protein generates a poliphosphorylated N 406 dimers able to sequestrate cellular 14-3-3 isoforms (Tugaeva et al., 2021) . 407

It has been recently demonstrated the existence of physical and functional interactions between 408 SARS-CoV-2 and host mitochondria, serving this organelle as a subcellular platform for anti-SARS-409

CoV-2 immunity (Flynn et al., 2021) . Although mitochondrial proteostasis was modified by all 410 SARS-CoV-2 structural proteins (Figure 3B) , our network analysis uncovered a generalized down-411 regulation of mitochondrial complex I subunits specifically induced by the expression of SARS-412

CoV-2 E and M proteins (Figure 6A, B) . Mitochondrial prohibitin complex (constituted by Phb1 and 413

Phb2 subunits) modulates mitochondrial dynamics and respiratory complex assembly, triggering 414 beneficial effects by reducing free radical production (Artal-Sanz and Tavernarakis, 2009; Zhou et al., 415 2012) . According to Biogrid database (https://thebiogrid.org/), Phb complex interacts with SARS-416

CoV-2 proteome at multiple levels. Specifically, Phb1 interacts with ORF9B/C, NSP2, NSP3, NSP6 417 and NSP8 whereas NSP2, NSP3, NSP6, ORF6, ORF9B, E and M proteins are Phb2 interactors. As 418 shown in Figure 6C , a depletion in Phb1 levels was observed in E protein expressing OBC1 cells. In 419 contrast, a significant increment in Phb2 levels was evidenced when S and N proteins were produced. 420

In general, Phb1 repression triggers a concomitant reduction of its partner Phb2 and viceversa 421 (Merkwirth et al., 2012) , indicating that SARS-CoV-2 structural proteins has the capacity to impact 422 on mitochondrial homeostasis differentially interfering with the functional interdependency of Phb 423 subunits. 424

The vast amount of information about the relationship between immune system and COVID-19 426 points out that multiple aberrations of innate and acquired immunity are induced by SARS-CoV-2 427

infection. Specifically, astrogliosis, microgliosis and infiltration by cytotoxic T lymphocytes in the 428 OB have been characterized in COVID-19 subjects (Matschke et al., 2020) . This olfactory 429 neuroinflammation is different from the observed in other brain areas (Schwabenland et al., 2021) . In 430 addition, it has been proposed that olfactory ensheating cells may produce glia transit tubules through 431 which cytokines and chemokines might migrate across the OE-OB axis (Xydakis et al., 2021) . 432

However, little is known about the immunological mechanisms triggered by each SARS-CoV-2 433 structural protein at olfactory level. In agreement with previous reports (Stukalov et al., 2021) , 434 specific gene/protein subsets modulated by each SARS-CoV-2 structural protein profile a pro-435 inflammatory signature (Supplemental Table 6 and Supplementary Figure 5) , inducing specific 436 changes in the OBC1 immunological effectome. As shown in Figure 7 , S protein expression 437

impacted on regulators of IL-6, IL-10 and IL-12 and in the differentiation of mature B cells. 438

Alterations in protein-coding genes relevant in inflammasomes, lymphocyte migration, response to 439 IL-7 and B cell activation were induced by the ex-pression of GFP-N protein expression in OBC1 440 cells (Figure 7) . On the other hand, the M protein had the potential to interfere with lymphocyte 441 activation, T cell differentiation, macrophage differentiation as well as in the IL-10, IL-27, and IL-35 442 signaling, whereas SARS-CoV-2 E protein specifically impacts on adaptive immune response, IL-17 443 pro-duction, B cell receptor signaling and natural killer cell differentiation between other processes 444 (Figure 7) . 445

We wanted to partially map the consequences over the intracellular immunological effectome 446 dependent on SARS-CoV-2 structural proteins. Cytokines and growth factors secreted by each stable 447 OB cell line constitutively expressing a GFP-tagged SARS-CoV-2 structural protein may provide 448 novel insights into the inflammatory imbalance produced by SARS-CoV-2. As shown in Figure 8 , 449 GFP-tagged M and E protein expression in OBC1 cells induced more extracellular changes. Part of 450 the 62 secreted cell-cell signaling molecules analyzed were commonly altered between the structural 451 proteins (Figure 8) . Specifically, the increment of RANTES (CCL5) and MIP3a (CCL20) levels in 452 the OBC1 secretome was independently induced by all structural proteins. Both chemokines are 453 elevated in sera from COVID-19 patients (Hue et al., 2020) . IFN gamma and MCP5 (CCL12) 454 extracellular levels were also increased in SARS-CoV-2 S, M and E protein-expressing OBC1 cells 455 (Figure 8) . Although most of the differential soluble mediators have been previously related to the 456 immune cell recruitment associated to COVID-19 cytokine storm (Ricci et al., 2021) , these data 457 contribute to the better understanding of the multifunctional immunomodulatory properties of SARS-458

CoV-2 M, N, S and E proteins beyond their intrinsic role in virion formation. 459

It has been previously demonstrated that sophisticated machine learning (ML) approaches are useful 462 workflows to integrate multi-omics data with the aim to discover complex interconnections between 463 different type of entities (Ebrahim et al., 2016; Mann et al., 2021) . To uncover regulatory complex 464 composed by molecular effectors potentially modulated by SARS-CoV-2 structural proteins at 465 olfactory level, transcriptomic and proteomic datasets were integrated and mined by a machine-466 learning approach in which multiple entities (genes, proteins, upstream regulators, pathways, 467 diseases) were interconnected in the form of knowledge graphs. Considering the IPA Z score as a 468 statistical measure of the match between expected relationship direction and observed gene/protein 469 expression, functional graphs were constructed. As shown in Figure 9 , common hubs were predicted 470 for each SARS-CoV-2 structural protein such as TGFB1/B3, SMAD and TEAD proteins, EGF, SPP1 471 and EDN1. It has been previously observed that SARS-CoV-2 N protein interacts with SMAD 472 proteins enhancing TGF-beta signaling (Wang et al., 2022) whereas SARS-CoV-2 S protein triggers 473 a transcriptional response associated to TGF-beta signaling (Biering et al., 2021) . Interestingly, a 474 therapeutic strategy focused on the inactivation of TGF-beta using integrin inhibitors has been 475

proposed to mitigate COVID-19 severity (Huntington et al., 2022) . EDN1 (Endothelin-1) has been 476 considered a neuroprotective factor that participates in the olfactory response modulation through the 477 uncoupling of gap junctions (Le Bourhis et al., 2014; Bryche et al., 2019) . Interestingly, elevated 478 EDN1 levels together with a sustained inflammation has been observed 3 months after recovery from 479 acute COVID-19 symptoms (Willems et al., 2021) . SPP1 (osteopontin) participates in the OB 480 synaptic plasticity (Powell et al., 2019) and acts as a molecular brake regulating neuroinflammatory 481 response to chronic viral infections (Mahmud et al., 2020) . Involved in the enhancing production of 482

interferon-gamma and interleukin-12, SPP1 is also overproduced in COVID-19 patients (Gibellini et 483 al., 2020) . 484

Although our study has uncovered the existence of commonalities and differences in the SARS-CoV-485 2 structural protein functionality, potential limitations exist that warrant discussion. It is important to 486 note that SARS-CoV-2 structural and non-structural protein interactions are absent in our study 487 (Boson et al., 2021; Xu et al., 2021) . We are aware that using our multi-omic approach, the molecular 488 dimension generated by posttranslational modifications (i.e phosphorylation) not only in host 489 proteins but also in the SARS-CoV-2 structural proteins (Stukalov et al., 2021) has not been 490 considered in this study, hampering the characterization of potential substrates modulated by the 491 virus-hijacked kinase activation profiles. Due to our experimental design, the overexpression of 492 exogenous proteins may generate drawbacks concerning protein misfolding, localization and 493 regulation as well as intrinsic limitations associated to GFP expression systems (Jensen, 2012) . Based 494 on the olfactory cellular system used, additional experiments are needed to verify the specific role of 495 the SARS-CoV-2 structural proteome in different human olfactory cellular contexts (Lachen-Montes 496 et al., 2020; Hatton et al., 2021) . As shown in previous reports performed at cellular and tissular 497 levels (Nie et al., 2021; Stukalov et al., 2021) , the application of proteomics in different olfactory cell 498 layers as well as in olfactory areas directly derived from COVID-19 individuals, would increase our 499 understanding of not only the early smell impairment associated to SARS-CoV-2 infection but also 500 the olfactory recovery potential in COVID-19 patients. Remaining significant terms were then hierarchically clustered into a tree based on Kappa-statistical 514 similarities among their gene memberships. 0.3 kappa score was applied as the threshold to cast the 515 tree into term clusters. The term with the best p value within each cluster was selected as its 516

representative term and displayed in a dendrogram. The heat map cells are coloured by their p values; 517

white cells indicate the lack of enrichment for that term in the corresponding protein/gene list. 518

Squares (black frame) highlight significantly enriched terms detected at transcript, protein levels or 519 both. 520 expression. MCODE algorithm (Bader and Hogue, 2003) was applied to automatically extract 522 protein complexes embedded in proteomics datasets. The three most significantly enriched ontology 523

terms were combined to annotate putative biological roles for each MCODE complex (Upper). Each 524 GFP-tagged SARS-CoV-2 protein differentially modulated each MCODE complex in OBC1 cells 525

(lower). 526 Commonalities and differences between proteostatic changes induced by the expression of SARS-532

CoV-2 structural proteins in olfactory OBC1 and pulmonary A549 cells (Stukalov et al., 2021) . 533 immunological capacity of OBC1 cells. Processes related to immune system were directly extracted 553 from the functional analysis of proteotranscriptomic datasets (see supplementary Table 6 for more 554 details). 555 were performed. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 vs 559 GFP. 560 precomputed table containing inferred relationships between molecules, functions, diseases, and 563 pathways obtained and scored by a machine learning algorithm operating entirely on prior 564

knowledge. The heuristic graph algorithm present in IPA software was optimized to create a 565 manageable network that brings together the most significantly activated (in orange; positive Z-566 score) or inhibited (in blue; negative z-score) upstream regulators, diseases, functions, and pathways 567 from the differential proteotranscriptomic alterations induced by each SARS-CoV-2 structural 568 proteins: A) SARS-CoV-2 E protein; B) SARS-CoV-2 M protein; C) SARS-CoV-2 N protein; D) 569 SARS-CoV-2 S protein. 

The authors declare that the research was conducted in the absence of any commercial or financial 625 relationships that could be construed as a potential conflict of interest. 626

References 627

Dysregulation in Akt/mTOR/HIF-1 signaling identified 630 by proteo-transcriptomics of SARS-CoV-2 infected cells

Prohibitin and mitochondrial biology

An automated method for finding molecular complexes in 635 large protein interaction networks

Coincidence of COVID-19 epidemic and olfactory dysfunction 639 outbreak in Iran

Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre 644 polymerase chain reaction based case-control study

SARS-CoV-2 Spike triggers 649 barrier dysfunction and vascular leak via integrins and TGF-beta signaling

The SARS-CoV-2 envelope and membrane proteins modulate maturation and 652 retention of the spike protein, allowing assembly of virus-like particles

The Global Phosphorylation Landscape of SARS-666

CoV-2 Infection

SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-672 19-associated anosmia

Endothelin 674 impacts on olfactory processing in rats

The olfactory nerve is not a 676 likely route to brain infection in COVID-19: a critical review of data from humans and animal 677 models

Virus-induced p38 MAPK activation facilitates 680 viral infection

COVID-19 and the Chemical Senses: Supporting Players Take Center Stage. 684 Neuron

Molecular interactions in the assembly of coronaviruses

COVID-19-related anosmia is associated with viral persistence and inflammation in 691 human olfactory epithelium and brain infection in hamsters

Correlates of critical illness-related 695 encephalopathy predominate postmortem COVID-19 neuropathology

SARS-CoV-2 envelope protein topology in eukaryotic membranes

Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43

The Olfactory Bulb: An Immunosensory Effector 704 Organ during Neurotropic Viral Infections

Multi-omic data integration enables 707 discovery of hidden biological regularities

Targeting 709 dendritic cell signaling to regulate the response to immunization

The membrane M protein carboxy 711 terminus binds to transmissible gastroenteritis coronavirus core and contributes to core 712 stability

Transcriptional landscape of SARS-CoV-2 infection 715 dismantles pathogenic pathways activated by the virus, proposes unique sex-specific 716 differences and predicts tailored therapeutic strategies

Discovery and 720 functional interrogation of SARS-CoV-2 RNA-host protein interactions

Activation of the c-Jun NH2-terminal kinase pathway by 723 coronavirus infectious bronchitis virus promotes apoptosis independently of c-Jun

PDL1 Signals through Conserved Sequence 728 Motifs to Overcome Interferon-Mediated Cytotoxicity

Rohlfs 739

Recent Smell Loss Is the Best Predictor

Among Individuals With Recent Respiratory Symptoms

Self-reported Olfactory 744 and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A 745 Cross-sectional Study

Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-750 19 pneumonia

Targeted data extraction of the MS/MS spectra generated by data-independent 753 acquisition: a new concept for consistent and accurate proteome analysis

p38 MAPK inhibition: A promising therapeutic approach for 756 COVID-19

COVID-19 and the 761 cardiovascular system: implications for risk assessment, diagnosis, and treatment options

Predictive Value of Sudden 764

Olfactory Loss in the Diagnosis of COVID-19

Delayed induction of type I and III interferons mediates nasal epithelial cell 771 permissiveness to SARS-CoV-2

Clinical 775 features of patients infected with 2019 novel coronavirus in Wuhan

Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with 780 COVID-19 Acute Respiratory Distress Syndrome

Integrin/TGF-beta1 inhibitor GLPG-0187 blocks SARS-CoV-2 Delta and Omicron 784 pseudovirus infection of airway epithelial cells which could attenuate disease severity

Use of fluorescent probes: their effect on cell biology and limitations

The olfactory route is a potential way for 791 SARS-CoV-2 to invade the central nervous system of rhesus monkeys

Graph-based genome 794 alignment and genotyping with HISAT2 and HISAT-genotype

Antiviral 797 potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East 798 respiratory syndrome coronavirus infection as identified by temporal kinome analysis

SortMeRNA: fast and accurate filtering of ribosomal 801 RNAs in metatranscriptomic data

Proteomics 803 Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the 804 Human Olfactory Axis

Molecular Derangements in the Olfactory Bulb of Tg2576 Mice: Novel Insights 808 Into the Stress-Responsive Olfactory Kinase Dynamics in Alzheimer's Disease. Front Aging 809 Neurosci 11

A mitochondrial RNAi screen defines cellular bioenergetic 812 determinants and identifies an adenylate kinase as a key regulator of ATP levels

Endothelin uncouples 815 gap junctions in sustentacular cells and olfactory ensheathing cells of the olfactory mucosa

The Sequence Alignment/Map 819 format and SAMtools

Early 825 Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

featureCounts: an efficient general purpose program for 828 assigning sequence reads to genomic features

Enzymatically inactive 830 adenylate kinase 4 interacts with mitochondrial ADP/ATP translocase

Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition. medRxiv

Olfactory bulb SARS-CoV-2 infection is 838 not paralleled by the presence of virus in other central nervous system areas

Neuropathology of COVID-19

Free Neuropathol 2

Moderated estimation of fold change and dispersion 845 for RNA-seq data with DESeq2

Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the 849 neuroinflammatory response to chronic viral infection

Artificial intelligence for proteomics 851 and biomarker discovery

Neuropathology of patients with 856 COVID-19 in Germany: a post-mortem case series

Olfactory transmucosal SARS-CoV-864 2 invasion as a port of central nervous system entry in individuals with COVID-19

Real-time tracking of self-reported symptoms to predict potential COVID-19

Postmortem examination of COVID-19 patients reveals diffuse 874 alveolar damage with severe capillary congestion and variegated findings in lungs and other 875 organs suggesting vascular dysfunction

Loss of prohibitin membrane scaffolds impairs mitochondrial 878 architecture and leads to tau hyperphosphorylation and neurodegeneration

Ultrastructural Evidence of Direct Viral Damage to the Olfactory Complex in Patients Testing 882 Positive for SARS-CoV-2

Insights into SARS-CoV-2 genome, structure, 885 evolution, pathogenesis and therapies: Structural genomics approach

Multi-892 organ proteomic landscape of COVID-19 autopsies

Qualimap 2: advanced multi-sample 894 quality control for high-throughput sequencing data

jPOSTrepo: an international standard data repository for proteomes

Author

More Than Smell-914 COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis

Structure and inhibition of the SARS coronavirus 918 envelope protein ion channel

Smell and taste changes are early 923 indicators of the COVID-19 pandemic and political decision effectiveness

Olfactory Bulb and Amygdala Gene Expression 928 Changes in Subjects Dying with COVID-19

Matrix 930

Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory 931 Bulb after Mild Traumatic Brain Injury

Glycogen synthase kinase-3: A 933 putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 934 pandemic

The S1 protein of SARS-CoV-2 937 crosses the blood-brain barrier in mice

Innate Immune 939 Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators

GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit 941 of Inhibiting Viral Replication While Potentiating the Immune Response

Cell-945 type-resolved quantitative proteomics map of interferon response against SARS-CoV-2

Structural Proteins in Severe Acute Respiratory Syndrome 948 Coronavirus-2

Coronavirus envelope protein: current knowledge

Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with 956 distinct microanatomical microglia-T-cell interactions

Mapping of SARS-CoV-2 Brain 963 Invasion and

Cell entry 965 mechanisms of SARS-CoV-2

The airborne lifetime of small speech 967 droplets and their potential importance in SARS-CoV-2 transmission

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-974

Nonlinear fitting method for determining local 976 false discovery rates from decoy database searches

The Mechanism of SARS-CoV

Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins

The Perseus computational platform for comprehensive analysis of (prote)omics data

SARTools: A DESeq2-and

EdgeR-Based R Pipeline for Comprehensive Differential Analysis of RNA-Seq Data. PLoS 985 One 11

SARS-CoV-2 N Protein Induces Acute Kidney Injury via

Dependent G1 Cell Cycle Arrest Mechanism

Sustained inflammation, coagulation activation and elevated endothelin-1 levels without 992 macrovascular dysfunction at 3 months after COVID-19

Compartmentalization-aided 994 interaction screening reveals extensive high-order complexes within the SARS-CoV-2 995 proteome

Post-viral effects of COVID-19 in the 998 olfactory system and their implications

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a 1001 systematic review and meta-analysis

SARS-CoV-2 infection in the mouse olfactory system

Prohibitin reduces mitochondrial free radical production and protects brain cells from 1007 different injury modalities

Metascape provides a biologist-oriented resource for the analysis of 1010 systems-level datasets